For Health Professionals - Association Of Acute Renal Failure (severe Kidney Problems) And Reports Of Cytopenias (low Blood Cell Counts) With Exjade (deferasirox)
Exjade Recall Summary Exjade (deferasirox) is being recalled in Canada due to reports of acute kidney failure and low blood cell counts in patients taking the medication. The recall affects all patients currently using Exjade across Canada. This medication is used to treat iron overload in patients with chronic blood transfusions or certain blood disorders.
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2007-03-19
- Status
- Closed
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/928b00f1-262f-4e15-850e-a4bf3a824967